Bamat; Michael K

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bamat; Michael K.The latest application filed is for "compounds and method for reducing uric acid".

Company Profile

0.19.21

Bamat; Michael K - Potomac MD
Bamat; Michael K. - Potomac MD US
Bamat; Michael K. - Chevy Chase MD
Bamat; Michael K. - Darnestown MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and method for reducing uric acid Grant 9,115,072 - O'Neil , et al. August 25, 2	2015-08-25
Compounds and method for reducing uric acid Grant 8,829,058 - O'Neil , et al. September 9, 2	2014-09-09
Method for the treatment of metabolic disorders Grant 8,604,083 - Sharma , et al. December 10, 2	2013-12-10
Compounds And Method For Reducing Uric Acid App 20130259850 - O'NEIL; James Dennen ; et al.	2013-10-03
Compounds And Method For Reducing Uric Acid App 20110014176 - O'Neil; James Dennen ; et al.	2011-01-20
Method for the treatment of metabolic disorders Grant 7,851,494 - Sharma , et al. December 14, 2	2010-12-14
Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides Grant 7,776,838 - von Borstel , et al. August 17, 2	2010-08-17
Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis Grant 7,709,459 - von Borstel , et al. May 4, 2	2010-05-04
Compounds For The Treatment Of Metabolic Disorders App 20080027229 - Sharma; Shalini ; et al.	2008-01-31
Compounds For The Treatment Of Metabolic Disorders App 20080021109 - Sharma; Shalini ; et al.	2008-01-24
Compounds For The Treatment Of Metabolic Disorders App 20080015209 - Sharma; Shalini ; et al.	2008-01-17
Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis Grant 7,307,166 - von Borstel , et al. December 11, 2	2007-12-11
Compounds For The Treatment Of Metabolic Disorders App 20070265323 - Sharma; Shalini ; et al.	2007-11-15
Compounds For The Treatment Of Metabolic Disorders App 20070265322 - Sharma; Shalini ; et al.	2007-11-15
Compounds For The Treatment Of Metabolic Disorders App 20070249719 - Sharma; Shalini ; et al.	2007-10-25
Compounds For The Treatment Of Metabolic Disorders App 20070249696 - Sharma; Shalini ; et al.	2007-10-25
Compounds For The Treatment Of Metabolic Disorders App 20070244171 - Sharma; Shalini ; et al.	2007-10-18
Compounds For The Treatment Of Metabolic Disorders App 20070244172 - Sharma; Shalini ; et al.	2007-10-18
Compounds For The Treatment Of Metabolic Disorders App 20070244141 - Sharma; Shalini ; et al.	2007-10-18
Compounds For The Treatment Of Metabolic Disorders App 20070105958 - Sharma; Shalini ; et al.	2007-05-10
Newcastle disease virus administration App 20070077559 - Bamat; Michael K. ; et al.	2007-04-05
Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis Grant 7,173,017 - von Borstel , et al. February 6, 2	2007-02-06
Acyl deoxyribonucleoside derivatives and uses thereof Grant 7,169,765 - Von Borstel , et al. January 30, 2	2007-01-30
Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides Grant 7,166,581 - von Borstel , et al. January 23, 2	2007-01-23
Compounds for the treatment of metabolic disorders App 20050256333 - Sharma, Shalini ; et al.	2005-11-17
Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis App 20040235782 - von Borstel, Reid W. ; et al.	2004-11-25
Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis App 20040220134 - von Borstel, Reid W. ; et al.	2004-11-04
Acyl deoxyribonucleoside derivatives and uses thereof App 20040192635 - Von Borstel, Reid W. ; et al.	2004-09-30
Acyl deoxyribonucleoside derivatives and uses thereof Grant 6,743,782 - Von Borstel , et al. June 1, 2	2004-06-01
Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis App 20040033981 - von Borstel, Reid W. ; et al.	2004-02-19
Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory heptitis App 20030212036 - von Borstel, Reid W. ; et al.	2003-11-13
Treatment Of Chemotherapeutic Agent And Antiviral Agent Toxicity With Acylated Pyrimidine Nucleosides App 20010025032 - VON BORSTEL, REID W. ; et al.	2001-09-27
Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis Grant 6,054,441 - von Borstel , et al. April 25, 2	2000-04-25
Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides Grant 5,968,914 - von Borstel , et al. October 19, 1	1999-10-19
Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides Grant 5,736,531 - von Borstel , et al. April 7, 1	1998-04-07
Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis Grant 5,691,320 - von Borstel , et al. November 25, 1	1997-11-25
Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine Grant 5,470,838 - von Borstel , et al. November 28, 1	1995-11-28
Methods for promoting wound healing with deoxyribonucleosides Grant 5,246,708 - von Borstel , et al. September 21, 1	1993-09-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.